US EditionPublished • loading... • Updated
NIT Rourkela startup receives CDSCO approval for StopBleed Hemostat
Summary by Express Pharma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
NIT Rourkela startup receives CDSCO approval for StopBleed Hemostat
National Institute of Technology Rourkela (NIT Rourkela) spinout startup Miraqules MedSolutions has received regulatory approval for the commercial manufacturing and clinical deployment of its patented rapid nano-biopolymer haemostat technology aimed at emergency haemorrhage control. India continues to face challenges in trauma care, with a significant proportion of road accident fatalities linked to delays in bleeding control. Many such inciden…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
